Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes

European Journal of Pharmacology

Volumn 720, Issue 1-3, 2013, Pages 376-382

  Stanley, Christopher P ^a   Wheal, Amanda J ^a   Randall, Michael D ^a   O'Sullivan, Saoirse E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anandamide; Cannabidiol; Diabetes; Endocannabinoid; Endothelium; Vasorelaxation

Indexed keywords

ACETYLCHOLINE; ANANDAMIDE; CANNABIDIOL; DRUG VEHICLE; ENDOCANNABINOID; NABIXIMOLS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM DEPENDENT VASORELAXATION; FEMORAL ARTERY; MALE; MESENTERIC ARTERY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASODILATATION; ZUCKER DIABETIC FATTY RAT;

ANANDAMIDE; CANNABIDIOL; DIABETES; ENDOCANNABINOID; ENDOTHELIUM; VASORELAXATION;

ANIMALS; AORTA, THORACIC; ARACHIDONIC ACIDS; CANNABIDIOL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; MALE; MESENTERIC ARTERIES; POLYUNSATURATED ALKAMIDES; RATS; RATS, ZUCKER; VASODILATION;

EID: 84890123300     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.002     Document Type: Article

References (37)

1. S. Bátkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, J. Liu, J. Harvey-White, L. Offertaler, K. Mackie, M.A. Rudd, R.D. Bukoski, and G. Kunos Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension Circulation 110 2004 1996 2002 (Pubitemid 39331913)
2. M.M. Bergamaschi, R.H. Queiroz, A.W. Zuardi, and J.A. Crippa Safety and side effects of cannabidiol, a Cannabis sativa constituent Current Drug Safety 6 2011 237 249
3. G.W. Booz Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress Free Radical Biology and Medicine 51 2011 1054 1061
4. A.S. De Vriese, T.J. Verbeuren, J. Van de Voorde, N.H. Lameire, and P.M. Vanhoutte Endothelial dysfunction in diabetes British Journal of Pharmacology 130 2000 963 974 (Pubitemid 30453529)
5. A.B. El-Remessy, M. Al-Shabrawey, Y. Khalifa, N.-T. Tsai, R.B. Caldwell, and G.I. Liou Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes American Journal of Pathology 168 2006 235 244 (Pubitemid 43062576)
6. C.J. Garland, F. Plane, B.K. Kemp, and T.M. Cocks Endothelium-dependent hyperpolarization: a role in the control of vascular tone Trends in Pharmacological Sciences 16 1995 23 30
7. G. Godlewski, S.O. Alapafuja, S. Bátkai, S.P. Nikas, R. Cinar, L. Offertaler, D. Osei-Hyiaman, J. Liu, B. Mukhopadhyay, J. Harvey-White, J. Tam, K. Pacak, J.L. Blankman, B.F. Cravatt, A. Makriyannis, and G. Kunos Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects Chemistry and Biology 17 2010 1256 1266
8. C.J. Hillard, W.S. Ho, J. Thompson, K.M. Gauthier, C.E. Wheelock, H. Huang, and B.D. Hammock Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619 British Journal of Pharmacology 152 2007 691 698 (Pubitemid 350034988)
9. F.F. Hoyer, M. Steinmetz, S. Zimmer, A. Becker, D. Lutjohann, R. Buchalla, A. Zimmer, and G. Nickenig Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo Journal of Molecular and Cellular Cardiology 51 2011 1007 1014
10. I. Matias, M.P. Gonthier, P. Orlando, V. Martiadis, L. De Petrocellis, C. Cervino, S. Petrosino, L. Hoareau, F. Festy, R. Pasquali, R. Roche, M. Maj, U. Pagotto, P. Monteleone, and V. Di Marzo Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia Journal of Clinical Endocrinology and Metabolism 91 2006 3171 3180 (Pubitemid 44271774)
11. 2 cannabinoid receptor - independent nitric oxide production in rabbit aortic endothelial cells Journal of Pharmacology and Experimental Therapeutics 321 2007 930 937 (Pubitemid 46762688)
12. F. Montecucco, and V. Di Marzo At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction Trends in Pharmacological Sciences 33 6 2012 331 340
13. N.J. Morrish, S.L. Wang, L.K. Stevens, J.H. Fuller, and H. Keen Mortality and causes of death in the WHO multinational study of vascular disease in diabetes Diabetologia 44 Suppl. 2 2001 S14 S21
14. 9- tetrahydrocannabinol Journal of Pharmacology and Experimental Therapeutics 317 2006 428 438
15. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Time-dependent vascular effects of endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARγ) PPAR Research 2009 2009 425289
16. 9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase Journal of Pharmacology and Experimental Therapeutics 321 2007 663 672 (Pubitemid 46624493)
17. S.E. O'Sullivan, Y. Sun, A.J. Bennett, M.D. Randall, and D.A. Kendall Time-dependent vascular actions of cannabidiol in the rat aorta European Journal of Pharmacology 612 2009 61 68
18. 9- tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma Biochemical and Biophysical Research Communications 337 2005 824 831 (Pubitemid 41446988)
19. C.L. Oltman, L.L. Richou, E.P. Davidson, L.J. Coppey, D.D. Lund, and M.A. Yorek Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats American Journal of Physiology - Heart and Circulatory Physiology 291 2006 H1780 H1787
20. D.J. Rademacher, S. Patel, W.S. Ho, A.M. Savoie, N.J. Rusch, K.M. Gauthier, and C.J. Hillard U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance American Journal of Physiology - Heart and Circulatory Physiology 288 2005 H2694 H2701
21. M. Rajesh, P. Mukhopadhyay, S. Bátkai, G. Hasko, L. Liaudet, V.R. Drel, I.G. Obrosova, and P. Pacher Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption American Journal of Physiology - Heart and Circulatory Physiology 293 2007 H610 H619
22. M. Rajesh, P. Mukhopadhyay, S. Bátkai, V. Patel, K. Saito, S. Matsumoto, Y. Kashiwaya, B. Horvath, B. Mukhopadhyay, L. Becker, G. Hasko, L. Liaudet, D.A. Wink, A. Veves, R. Mechoulam, and P. Pacher Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy Journal of the American College of Cardiology 56 2010 2115 2125
23. D.M. Randall, A.D. Kendall, and O.S. Saoirse The complexities of the cardiovascular actions of cannabinoids British Journal of Pharmacology 142 2004 20 26
24. M.R. Romano, and M.D. Lograno Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery European Journal of Pharmacology 683 2012 197 203
25. M.G. Signorello, E. Giacobbe, M. Passalacqua, and G. Leoncini The anandamide effect on NO/cGMP pathway in human platelets Journal of Cellular Biochemistry 112 2011 924 932
26. S. Singla, R. Sachdeva, and J.L. Mehta Cannabinoids and atherosclerotic coronary heart disease Clinical Cardiology 35 6 2012 329 335
27. C.P. Stanley, W.H. Hind, and S.E. O'Sullivan Is the cardiovascular system a therapeutic target for cannabidiol? British Journal of Clinical Pharmacology 75 2 2012 313 322
28. S. Steffens, N.R. Veillard, C. Arnaud, G. Pelli, F. Burger, C. Staub, M. Karsak, A. Zimmer, J.L. Frossard, and F. Mach Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice Nature 434 2005 782 786 (Pubitemid 44739523)
29. C.C. Toth, N.M. Jedrzejewski, C.L. Ellis, and W.H. Frey II Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type 1 diabetic peripheral neuropathic pain Molecular Pain 6 2010 16
30. P.M. Vanhoutte Endothelial dysfunction: the first step toward coronary arteriosclerosis Circulation Journal 73 2009 595 601
31. P.M. Vanhoutte, H. Shimokawa, E.H. Tang, and M. Feletou Endothelial dysfunction and vascular disease Acta Physiologica (Oxford) 196 2009 193 222
32. 1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts Journal of Cardiovascular Pharmacology 47 2006 650 655 (Pubitemid 44309657)
33. L. Weiss, M. Zeira, S. Reich, M. Har-Noy, R. Mechoulam, S. Slavin, and R. Gallily Cannabidiol lowers incidence of diabetes in non-obese diabetic mice Autoimmunity 39 2006 143 151 (Pubitemid 43675258)
34. L. Weiss, M. Zeira, S. Reich, S. Slavin, I. Raz, R. Mechoulam, and R. Gallily Cannabidiol arrests onset of autoimmune diabetes in NOD mice Neuropharmacology 54 2008 244 249 (Pubitemid 350299408)
35. A.J. Wheal, T. Bennett, M.D. Randall, and S.M. Gardiner Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro British Journal of Pharmacology 150 2007 662 671 (Pubitemid 46355560)
36. A.J. Wheal, and M.D. Randall Effects of hypertension on vasorelaxation to endocannabinoids in vitro European Journal of Pharmacology 603 2009 79 85
37. 2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules Journal of Cardiovascular Pharmacology 55 2010 292 298